Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Telemedicine in Heart Failure During COVID-19: A Step Into the Future

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • بيانات النشر:
      FRONTIERS MEDIA SA
    • الموضوع:
      2021
    • Collection:
      Document Server@UHasselt (Universiteit Hasselt)
    • نبذة مختصرة :
      During the Coronavirus Disease 2019 worldwide pandemic, patients with heart failure are a high-risk group with potential higher mortality if infected. Although lockdown represents a solution to prevent viral spreading, it endangers regular follow-up visits and precludes direct medical assessment in order to detect heart failure progression and optimize treatment. Furthermore, lifestyle changes during quarantine may trigger heart failure decompensations. During the pandemic, a paradoxical reduction of heart failure hospitalization rates was observed, supposedly caused by patient reluctance to visit emergency departments and hospitals. This may result in an increased patient mortality and/or in more complicated heart failure admissions in the future. In this scenario, different telemedicine strategies can be implemented to ensure continuity of care to patients with heart failure. Patients at home can be monitored through dedicated apps, telephone calls, or devices. Virtual visits and forward triage screen the patients with signs or symptoms of decompensated heart failure. In-hospital care may benefit from remote communication platforms. After discharge, patients may undergo remote follow-up or telerehabilitation to prevent early readmissions. This review provides a comprehensive appraisal of the many possible applications of telemedicine for patients with heart failure during Coronavirus disease 2019 and elucidates practical limitations and challenges regarding specific telemedicine modalities. ; JD is a researcher for the Limburg Clinical Research Center (LCRC) UHasselt-ZOL-Jessa, supported by the foundation Limburg Sterk Merk (LSM), province of Limburg, Flemish government, Hasselt University, Ziekenhuis Oost-Limburg, and Jessa Hospital. ; Tersalvi, G (corresponding author), Fdn Cardioctr Ticino, Div Cardiol, Lugano, Switzerland. Hirslanden Klin St Anna, Dept Internal Med, Luzern, Switzerland. tersalvi@gmail.com
    • File Description:
      application/pdf
    • Relation:
      Frontiers in Cardiovascular Medicine, 7 (Art N° 612818); http://hdl.handle.net/1942/33249; WOS:000600937000001
    • الرقم المعرف:
      10.3389/fcvm.2020.612818
    • الدخول الالكتروني :
      https://doi.org/10.3389/fcvm.2020.612818
      http://hdl.handle.net/1942/33249
    • Rights:
      Copyright © 2020 Tersalvi, Winterton, Cioffi, Ghidini, Roberto, Biasco, Pedrazzini, Dauw, Ameri and Vicenzi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. ; info:eu-repo/semantics/openAccess
    • الرقم المعرف:
      edsbas.4AD5B639